Table 2.
Nucleotide mutation and amino acid substitution in HPV-31 E6
| HPV-31 E6 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| Location | 27 | 69 | 141 | 178 | 190 | 194 | 205 | 219 | 228 | 297 | 321 | 368 | 413 |
| Mutation | T–A | C–T | T–C | C–T | A–G | A–G | T–C | A–G | T–C | G–A | A–G | A–G | C–T |
| Frequency (%) | 8.33 | 27.08 | 4.17 | 31.25 | 4.17 | 2.08 | 4.17 | 16.67 | 2.08 | 31.25 | 27.08 | 4.17 | 35.42 |
| Substitution | – | – | – | H60Y | T64A | K65R | F69L | – | – | – | – | K123R | A138V |
Compared with the HPV-31 E6 reference sequence (J04353), the mutations are marked with the corresponding bases and amino acid, and those without changes are replaced with a dash (–). No. means the number of nucleotide mutations, Location means the sites of nucleotide mutations, Mutation means the style of nucleotide mutations, Frequency (%) means the percentage of nucleotide mutations, Substitution means the amino acid substitution that occurred by nucleotide mutations